Latest News
Gendius is one of four digital healthcare projects supporting the COVID-19 response awarded a share of £200,000 through Health Innovation Manchester Momentum Fund.
Artificial Intelligence to support patients to manage their diabetes, a Clin...
The AMR Centre has combined forces to attract much needed investment to combat the global threat of antimicrobial resistance (AMR) resulting in a successful bid for a £114 million project supported by UK Research and Innovation (UKRI).&...
AstraZeneca has signed a ‘memorandum of understanding’ with UK medtech start-up Gendius to develop their leading diabetes management platform (Intellin®) and support patients in Gulf Cooperation Council (GCC) countries, whi...
Catapult portfolio businesses Elucid Digital Health and Clin-e-Cal have both been included in the 2020 Business Cloud 100 HealthTech Pioneers list - featuring the UK’s leading health and medical technology companies.
The final ranking...
Intellin® is an intelligent remote management diabetes platform, with over 140,000 downloads so far this this year. Having established itself as an approved vendor with Big Pharma, the company is now poised to scale the business globally and d...